Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25808438)

  • 1. Personalized treatment for patients with colorectal cancer: role of biomarkers.
    Duffy MJ
    Biomark Med; 2015; 9(4):337-47. PubMed ID: 25808438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
    De Mattia E; Cecchin E; Toffoli G
    Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
    Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
    World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of biomarkers in colorectal cancer.
    Newton KF; Newman W; Hill J
    Colorectal Dis; 2012 Jan; 14(1):3-17. PubMed ID: 21040359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Study of the Predictive Value of Target Now in Systemic Therapy for Metastatic Colorectal and Gastric Carcinomas.
    Cohen JE; Cohen Y; Peretz T; Hubert A
    Isr Med Assoc J; 2015 Oct; 17(10):612-5. PubMed ID: 26665314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
    Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
    Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing chemotherapeutic treatment of colorectal cancer.
    Crews KR
    Am J Health Syst Pharm; 2006 May; 63(9 Suppl 2):S12-7. PubMed ID: 16641252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent applications of chemosensitivity tests for colorectal cancer treatment.
    Yoon YS; Kim JC
    World J Gastroenterol; 2014 Nov; 20(44):16398-408. PubMed ID: 25469008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.
    De Divitiis C; Nasti G; Montano M; Fisichella R; Iaffaioli RV; Berretta M
    World J Gastroenterol; 2014 Nov; 20(41):15049-59. PubMed ID: 25386053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
    Maurel J; Postigo A
    Curr Cancer Drug Targets; 2015; 15(8):703-15. PubMed ID: 26452385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
    Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
    Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations.
    Custodio A; Feliu J
    Crit Rev Oncol Hematol; 2013 Jan; 85(1):45-81. PubMed ID: 22647972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
    Dienstmann R; Salazar R; Tabernero J
    Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.
    Asghar U; Hawkes E; Cunningham D
    Clin Colorectal Cancer; 2010 Dec; 9(5):274-81. PubMed ID: 21208841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
    Akkad J; Bochum S; Martens UM
    Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biomarker for chemotherapy in patients with colorectal cancer].
    Matsusaka S
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of biomarkers to guide the treatment of metastatic colorectal cancer.
    Davis LE
    Am J Manag Care; 2018 Apr; 24(7 Suppl):S107-S117. PubMed ID: 30207665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.